King Bio-Medical代理，King Bio-Medical上海代理，King Bio-Medical北京代理，King Bio-Medical 總代理，King Bio-Medical一級(jí)代理，King Bio-Medical國(guó)內(nèi)代理
上海起發(fā)實(shí)驗(yàn)試劑有限公司King Bio-Medical專業(yè)代理，具體產(chǎn)品信息歡迎電詢：

Congenital Factor II Deficient Plasma

Factor II Deficient plasma is drawn from a human donor with a congenital deficiency.

·         Human plasma from donor with congenital FII Deficiency

·         Substrate quality

·         FII Activity printed on each vial

·         No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

Congenital Factor V Deficient Plasma

·         Human plasma from donor with congenital FV Deficiency

·         Substrate quality

·         <1% FV Activity by one stage clotting assay

·         No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

Congenital Factor VII Deficient Plasma

Factor VII Deficient plasma is drawn from a human donor with a congenital deficiency.

·         Human plasma from donor with congenital FVII Deficiency

·         Substrate quality

·         <1% FVII Activity by one stage clotting assay

·         No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

Congenital Factor VIII Deficient Plasma

Factor VIII Deficient plasma is drawn from a human donor with a congenital deficiency.

·         Human plasma from donor with congenital FVIII Deficiency

·         Substrate quality

·         <1% FVIII Activity by one stage clotting assay

·         No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

Congenital Factor IX Deficient Plasma

Factor IX Deficient plasma is drawn from a human donor with a congenital deficiency.

·         Human plasma from donor with congenital FIX Deficiency

·         Substrate quality

·         <1% IX Activity by one stage clotting assay

·         No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma (monospecificity).

上海起發(fā)實(shí)驗(yàn)試劑有限公司
：楊建輝
：
辦公：
*8006

:
:http://www.qfbio.com/
地址：上海市浦東新區(qū)繡川路561號(hào)1102室